-+ 0.00%
-+ 0.00%
-+ 0.00%

Addex Therapeutics appoints Jean-Philippe Rocher head of pharmaceutical development

PUBT·10/02/2026 05:02:04
Addex Therapeutics appoints Jean-Philippe Rocher head of pharmaceutical development
  • Addex Therapeutics named Jean-Philippe Rocher head of pharmaceutical development, adding him to executive management.
  • Rocher previously led pharmaceutical development at Neurosterix, joined Addex at inception in 2002, later served as CNS program director at Pierre Fabre.
  • Mikhail Kalinichev stepped down as head of translational science to focus on a similar role at Neurosterix.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Addex Therapeutics Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020100PRIMZONEFULLFEED1001275845) on October 02, 2026, and is solely responsible for the information contained therein.